Background and Objectives: Attention-Deficit Hyperactivity Disorder (ADHD) is a neurological condition characterized by cognitive task difficulty, impulsivity, hyperactivity and loss of attention. This study compared four approaches for improving attention and related skills in school-age children: COGO Brain–Computer Interface (BCI)-based attention training, methylphenidate, citicoline, and their combined use. Materials and Methods: A quasi-experimental pre–post design was used with four groups: COGO + methylphenidate (n = 44), COGO + citicoline (n = 44), COGO-only (n = 44), and citicoline-only (n = 42). Children completed baseline and post-treatment assessments, including the CPT-3 and several behavioral and emotional rating scales. Analyses included paired t-tests, ANCOVA, and repeated-measures ANOVA, adjusting for age. Results: The strongest improvements appeared in the COGO + methylphenidate group, especially in measures of sustained attention and reaction time consistency. The COGO + citicoline group showed clearer gains in inhibitory control (fewer commission errors) and reductions in anxiety/emotional symptoms. The COGO-only and citicoline-only groups showed little to no measurable change. Despite these within-group patterns, there were no significant differences between groups on CPT-3 outcomes or behavioral/emotional scales. Conclusions: This trial showed that combining COGO-based attention training with medication is both feasible and well-tolerated in children with attention and executive function difficulties. Moreover, the integrated approach produced measurable improvements across attentional performance and behavioral regulation domains.
Turan et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: